Monitoring symptoms to improve medication use in breast cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests if tracking how you feel and reporting your symptoms can help women with hormone receptor-positive breast cancer take their hormone-blocking medication more consistently. It may be a good fit if you have been prescribed aromatase inhibitors or similar therapy and have had trouble taking it as directed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a cisgender woman (assigned female at birth) and 18 or older.
- You have stage 1, 2, or 3 hormone receptor-positive breast cancer.
- You have been recommended to continue hormone-blocking therapy for at least 2 more years.
- You have had low adherence to this therapy in the past 2 years (less than 80% of prescribed doses taken).
- You are fluent in English or Spanish.
- You are not pregnant, not trying to get pregnant, and do not have cancer that has spread to distant organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.
This study tests whether a medication called bupropion can help women with hormone receptor-positive breast cancer who are taking aromatase inhibitors (drugs that block estrogen) but experiencing low sexual desire as a side effect. The goal is to see if this approach improves both tolerance to the cancer medication and quality of life.
This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.
This study tests a program to help people with metastatic breast cancer take their endocrine therapy, CDK4/6 inhibitors, and heart-related medications as prescribed. If you sometimes miss doses of these medicines, you may be able to join.
This study tests whether text message reminders help women with early-stage, hormone-sensitive breast cancer remember to take their daily cancer-prevention medication. The goal is to see if reminders improve how consistently women take their pills, which can help prevent cancer from coming back.
This trial tests an intervention to help improve how equitably people take their prescribed breast cancer hormone therapy and heart-related prevention medicines. It may help if you have had trouble taking these medications as directed.
Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.